Epstein-barr Virus-positive Solid Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2018-04-24
Clinical Trial Update: Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors [Phase 1]
Phase 1 safety and tolerability study of everolimus (RAD001) plus panobinostat (LBH589) in EBV-driven solid tumors, including nasopharyngeal…